Vitality Watch

Dossier pubmed preclinical 07-aug-2026
Animal model, organoid, or cell-culture result — not yet human

MDM2 deletion and its associated p53 activation in subcutaneous white adipose tissue induce hepatic fibrosis via galectin-3 in a mouse model.

Key claim: Selective MDM2 deletion and sustained p53 activation in subcutaneous adipose tissue trigger adipocyte senescence and promote hepatic fibrosis via increased galectin-3 secretion.

Abstract

BACKGROUND: White adipose tissue (WAT) communicates with distal metabolic organs and regulates their functions by secreting adipokines. Subcutaneous WAT (sWAT) is thought to be metabolically protective but prone to dysfunction with aging and obesity. Chronic activation of p53 is commonly observed in dysfunctional WAT at different anatomical locations in metabolic diseases. However, the impact of MDM2 deletion and its associated p53 activation in sWAT on adipokine profile and systemic metabolism is unknown. METHODS AND RESULTS: To investigate the effects of selective MDM2 deletion and its associated p53 activation in sWAT, we administered two independent adipotropic adeno-associated virus (AAV) vectors expressing Cre recombinase into the sWAT of Mdm2mice to locally delete MDM2, a well-established negative regulator that targets p53 for degradation. Deletion of MDM2 resulted in sustained p53 activation, leading to senescence, apoptosis, and fibrosis in sWAT, but not in other fat depots or metabolic organs. sWAT dysfunction resulting from MDM2 deletion and its associated p53 activation had no obvious impact on systemic glucose or lipid metabolism, but progressively triggered hepatic inflammation, damage, and fibrosis. Proteomic analysis revealed that MDM2 deletion shifted the sWAT adipokine profile toward a more pro-inflammatory and pro-fibrotic state. Among the MDM2 deletion-induced sWAT-derived factors, galectin-3 acted as a major contributor to hepatic stellate cell activation and fibrogenesis via STAT3 signaling. At the molecular level, p53 bound to the Lgals3 promoter and upregulated its mRNA expression, thereby increasing galectin-3 secretion primarily in mature adipocytes. CONCLUSION: Our findings reveal that sWAT dysfunction caused by MDM2 deletion and its associated p53 activation is sufficient to promote hepatic damage and fibrosis.

Why this matters

[animal-model] This finding gives the interorgan senescence model a specific tissue of origin and secreted mediator: experimentally induced p53 activation in subcutaneous fat promotes liver fibrosis through adipocyte-derived galectin-3. [animal-model] It shows that subcutaneous fat can transmit harmful signals under this perturbation, but does not establish that the pathway drives ordinary human aging or that galectin-3 blockade or senolytic treatment would prevent human liver fibrosis.

Source

Link

Briefing card

MDM2 deletion and its associated p53 activation in subcutaneous white adipose tissue induce hepatic fibrosis via galectin-3 in a mouse model.
Stage: preclinical · pubmed · 07-aug-2026

Selective MDM2 deletion and sustained p53 activation in subcutaneous adipose tissue trigger adipocyte senescence and promote hepatic fibrosis via increased galectin-3 secretion.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.metabol.2026.156726

build build 880 · 2bcef25 · 2026-11-18